Longitudinal characterization of biomarkers for spinal muscular atrophy

U Bonati, Š Holiga, N Hellbach… - Annals of clinical …, 2017 - Wiley Online Library
Objective Recent advances in understanding Spinal Muscular Atrophy (SMA)
etiopathogenesis prompted development of potent intervention strategies and raised need …

[HTML][HTML] Longitudinal characterization of biomarkers for spinal muscular atrophy

U Bonati, Š Holiga, N Hellbach… - Annals of Clinical and …, 2017 - ncbi.nlm.nih.gov
Objective Recent advances in understanding Spinal Muscular Atrophy (SMA)
etiopathogenesis prompted development of potent intervention strategies and raised need …

Longitudinal characterization of biomarkers for spinal muscular atrophy

U Bonati, Š Holiga, N Hellbach… - Annals of Clinical …, 2017 - search.proquest.com
Objective Recent advances in understanding Spinal Muscular Atrophy (SMA)
etiopathogenesis prompted development of potent intervention strategies and raised need …

Longitudinal characterization of biomarkers for spinal muscular atrophy

U Bonati, Š Holiga, N Hellbach… - Annals of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
Objective Recent advances in understanding Spinal Muscular Atrophy (SMA)
etiopathogenesis prompted development of potent intervention strategies and raised need …

Longitudinal characterization of biomarkers for spinal muscular atrophy

U Bonati, Š Holiga, N Hellbach, C Risterucci… - … OF CLINICAL AND …, 2017 - ricerca.uniba.it
Recent advances in understanding Spinal Muscular Atrophy (SMA) etiopathogenesis
prompted development of potent intervention strategies and raised need for sensitive …

Longitudinal characterization of biomarkers for spinal muscular atrophy.

U Bonati, Š Holiga, N Hellbach, C Risterucci… - Annals of clinical and …, 2017 - folia.unifr.ch
METHODS 18 SMA patients and 19 healthy volunteers (HV) were followed in this 52-weeks
observational study. Quantitative-MRI (qMRI) of both thighs and clinical evaluation of motor …

Longitudinal characterization of biomarkers for spinal muscular atrophy

U Bonati, Š Holiga, N Hellbach, C Risterucci… - Annals of Clinical and …, 2017 - pure.mpg.de
Objective Recent advances in understanding Spinal Muscular Atrophy (SMA)
etiopathogenesis prompted development of potent intervention strategies and raised need …

Longitudinal characterization of biomarkers for spinal muscular atrophy.

U Bonati, Š Holiga, N Hellbach, C Risterucci… - Annals of clinical and …, 2017 - sonar.ch
METHODS 18 SMA patients and 19 healthy volunteers (HV) were followed in this 52-weeks
observational study. Quantitative-MRI (qMRI) of both thighs and clinical evaluation of motor …

Longitudinal characterization of biomarkers for spinal muscular atrophy.

U Bonati, Š Holiga, N Hellbach… - Annals of Clinical and …, 2017 - europepmc.org
Objective Recent advances in understanding Spinal Muscular Atrophy (SMA)
etiopathogenesis prompted development of potent intervention strategies and raised need …

Longitudinal characterization of biomarkers for spinal muscular atrophy.

U Bonati, Š Holiga, N Hellbach… - Annals of Clinical & …, 2017 - search.ebscohost.com
Objective Recent advances in understanding Spinal Muscular Atrophy (SMA)
etiopathogenesis prompted development of potent intervention strategies and raised need …